Navigation Links
PARI Pharma Unveils Closed System Using eFlow Technology at Medical Plastics Conference
Date:10/6/2008

MONTEREY, Calif., Oct. 6 /PRNewswire/ -- Today, PARI Pharma GmbH will unveil a prototype Closed System using eFlow Technology that uses single dose ampoules to control medication used in the nebulizer system. By creating a proprietary, unit-dose ampoule that is required to operate the nebulizer, the Closed System using eFlow Technology meets an unmet need by reducing the risk of using the wrong medication in the delivery device, simplifying filling procedures, improving dose uniformity and hygiene.

"This is a very exciting period in inhalation drug development. Building on our ability to customize a delivery device and a medication formulation, we have been able to take eFlow Technology a step further by creating an aerosol device that will only deliver its matching formulation. This has a number of advantages for our pharmaceutical partners, physicians, and patients. The Closed System using eFlow Technology takes away the risk of someone putting anything other than their prescribed medication into an advanced delivery device, while keeping medication sealed until it is opened in the nebulizer," said Geoff A. Hunziker, president of eFlow LLC. "As new device technologies develop, it is critical for safety and efficacy to ensure patients use the approved delivery device for the inhaled drug."

Thomas Gallem, director of product design of PARI Pharma, will present "Development of a closed, ampoule-based electronic nebulizer system -- next step in drug-device combination for liquid aerosol therapy" at the 22nd Annual Medical Plastics Conference in Copenhagen, Denmark today.

PARI Pharma is currently in discussions about introducing the Closed System using eFlow Technology into new clinical development programs with pharmaceutical partners.

About eFlow Technology

eFlow Technology enables extremely efficient aerosolization of liquid medications via a vibrating, perforated membrane that includes thousands of small holes that produce
'/>"/>

SOURCE PARI Pharma GmbH
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related medicine news :

1. Anemia and tropical diseases; Is pharmacogenomics ready for the clinic?
2. Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Mercks Generic Pharmaceutical Business
3. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
4. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
5. The Pharma & Life Sciences Best Practice Database: an Industry Resource for Successful Techniques and Performance Benchmarks for Reaching the Top
6. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
7. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
8. National Pharmaceutical Council Announces New Strategic Focus, Search for New Leadership
9. AKELA Pharma Inc. announces positive results for the extension part of its Phase IIb Fentanyl TAIFUN(R) trial
10. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Coreg(R)
11. Innocoll Agrees the Sale of its CollaRx(R) GENTAMICIN SURGICAL IMPLANT and European Sales and Marketing Infrastructure to EUSA Pharma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/8/2009)...ions offers five action steps to improve response ...-- Despite the recent three-hour cease fires to al...esidents of the Palestinian territory, upwards of ...ter and medical help. U.S.-based international hum...see this arrangement to allow sporadic delivery of...
(Date:1/8/2009)... of cancer cells are keys to the development of a ...e spread of certain types of cancers called carcin...lung, among others. Armed with a new two-year gra...ch, an Illinois-based philanthropic foundation, im... co-workers at the Moores Cancer Center at the Uni...
(Date:1/8/2009)... at his confirmation hearing to be the next Secret...GTON, Jan. 8 Bipartisan... Tom Daschle, nominee for Department of Health and...w BPC founder and friend Senator Bob Dole at his c...d by the Senate Health, Education, Labor, and Pens...
(Date:1/8/2009)...ctor in Decision for Florida Multi-Specialty Group...wire-FirstCall/ -- Allscripts announced today that...i-specialty group practices in the Southeast Unite...M) Electronic Health Record (EHR) to automate and ...entral Florida. , , (Logo: http://www.newsco...
Breaking Medicine News(10 mins):Health News:Temporary Cease Fires Not Enough for Humanitarian Aid Groups Working in Gaza 2Health News:Temporary Cease Fires Not Enough for Humanitarian Aid Groups Working in Gaza 3Health News:Novel prostate cancer vaccine taking aim at cancer cell 'sweet spot' 2Health News:Bipartisan Policy Center Founding Board Members Daschle and Dole Appear on Capitol Hill 2Health News:Bipartisan Policy Center Founding Board Members Daschle and Dole Appear on Capitol Hill 3Health News:Bipartisan Policy Center Founding Board Members Daschle and Dole Appear on Capitol Hill 4Health News:Physician Associates, LLC Selects Allscripts Electronic Health Record to Connect and Automate 80 Physicians 2Health News:Physician Associates, LLC Selects Allscripts Electronic Health Record to Connect and Automate 80 Physicians 3Health News:Physician Associates, LLC Selects Allscripts Electronic Health Record to Connect and Automate 80 Physicians 4
...uire better memories, literacy skills and math ski...y was conducted by// Laurel Trainor, professor of ...University in Hamilton, Ontario and her team. The... aged 4-6. They took a music test after attending ...
... a pack-a-day crisp habit is prevalent among 55% o...alent of five litres of// cooking oil annually. T...g people about the amount of hidden salt, fat and ...were releases as a part of it. 'I am concerned we ...
...d Journal of Medicine says that stem cells may not...h is needed to ascertain// these findings. Three ...o survivors of heart attacks and found that these ...maged hearts. Researchers looked at whether stem c...
...t is considering introducing a needle exchange pro...king can trigger// diseases like Hepatitis C and H...y have shared needles in prison. There will always...in prison," a SPS spokesman told BBC. "If you're n...
Other Medicine News:
(Date:1/6/2009)...ry 6 , - Early Re... Until,December 2011 , - Expansion of the ...scovery in Ophthalmology , - Revised Commer...blicenses to a Third Party , ExonHit Ther...forcement,of its existing drug discovery collabor...
(Date:1/5/2009)...5 Micromet, Inc.,(Nasda...g novel, proprietary,antibodies for the treatment...,provides an outlook on key events anticipated for...vide an update on its research and development,pr...12 to 16, 2009: Update on several preclinical BiTE...
(Date:1/3/2009)... , ROSEMONT, Ill., Jan. 2 /PRNewswire-USNewswire/...technology providing an increasing number of clini...ain according to an article in the January 2009 is...opaedic Surgeons ( http://www.jaaos.org/ ). It is...ional technical developments will allow MRI to pro...
(Date:12/29/2008)...PRNewswire-USNewswire/ -- The winner of the 2008 A...as announced today by Dr. Peter G. Goldschmidt, Pr...itute. , , The winner of the annual award was ...enter -- for its best practice " IND Regulatory ...r 1) enhanced human subjects protection, 2) improv...
Breaking Medicine Technology:ExonHit Therapeutics Expands Strategic Collaboration With Allergan 2ExonHit Therapeutics Expands Strategic Collaboration With Allergan 3ExonHit Therapeutics Expands Strategic Collaboration With Allergan 4Micromet Key Events for 2009 2Micromet Key Events for 2009 3Micromet Key Events for 2009 4Micromet Key Events for 2009 5MRI Emerges As Vital Resource in Treatment of Back Pain 2MRI Emerges As Vital Resource in Treatment of Back Pain 32008 Human Research Protection Award Recipients Announced 2Hospice Programs Nationwide Urge Congress to Act on Behalf of End of Life Patients 22308 1Hospice Programs Nationwide Urge Congress to Act on Behalf of End of Life Patients 22308 2Dilon Technologies Announces National Agreement with MedAssets 22306 1Dilon Technologies Announces National Agreement with MedAssets 22306 2Quintiles Appoints New Executives 6110 1Quintiles Appoints New Executives 6110 2New findings on immune system in amphibians 3703 1New findings on immune system in amphibians 3703 2
A rapid rise in intracranial pressure requires early recognition, intervention and continuous monitoring. Ventrix utilizes state-of-the-art fiberoptic technology that gets to the source of pressure.
The MPM-1 offers a broad range of functions to attain new levels of parenchymal and ventricular monitoring through fiberoptic technology at the source.
The Codman ICP Monitoring System provides highly accurate measurements of intracranial pressure at the source-subdural, parenchymal or intraventricular levels. The information is relayed electronical
The Polaris system delivers the most innovative optical tracking technology. Compact, cost effective and easy to use, this unique system combines the highest level of precision measurement with unpre
Medicine Products: